An experimental mRNA-based treatment has been reported to prompt damaged heart cells to divide, according to أخبار 24. The outlet published the report on Monday, 9 November 2026.
The story was picked up across several Arabic-language outlets. Coverage described the approach as a way to give heart muscle a chance to repair itself, and one report framed it as a potential shift in how cardiac disease is treated. Another described it as an experimental drug that reactivates cells to fix heart muscle damage following heart attacks.
A related report from الجزيرة نت focused on the identification of a protein that could allow the heart to address its own crises, suggesting the research centers on biological signals that control whether heart cells regenerate.
The reports did not include trial data, patient numbers, or a timeline for clinical use, and أخبار 24's account did not specify who is developing the treatment or at what stage testing stands.
What to watch next: whether the researchers release detailed study results, including which patients were involved and how the therapy performed.